Background: Abnormal uterine bleeding (AUB), affects 10‑30% of reproductive‑age group women and constitute about one‑third of all outpatient gynecological visits. can normalize blood flow in women with heavy menstrual blood loss, as high level of levonorgestrel released locally induces considerable effects leading to the distinctive mode of therapeutic along with contraceptive action. The study aimed to study the efficacy of LNG-IUS in women with AUB. Methods: This prospective interventional study was carried out at a private hospital in Haryana, over a period of 5years. A total of 50 women suffering from AUB, who underwent LNG-IUS insertion were included in study. The effectiveness of device was assessed by reduction in amount of blood loss, symptomatic improvement along with improvement in quality of life. The participants were followed-up after 1st, 3rd, and 6th month of insertion. Results: The mean subjective percentage reduction in blood loss reduced from 13.64% at the first visit to 72.16% at the end of 6th month. The mean Hb level improved from 6.8gm/dl to 9.8gm/dl at the end of 6th month. Conclusions: The LNG-IUS, provides a miraculous, cost-effective, non-surgical alternative in treatment of menorrhagia due to benign pathologies like endometrial polyps, adenomyosis and endometrial hyperplasia. Key words: Abnormal Uterine Bleeding, LNG-IUS, Menorrhagia, Mirena, Adenomyosis, Endometrial Polyp.
Dahiya et al. (2025) studied this question.